CXCL2 and non-small cell lung carcinoma: In the current study, we successfully profiled the expression of CXCL2 at single- and bulk-cell levels in four human NSCLC epithelial cell lines using Fluidigm 3′-end scRNA-seq and qRT-PCR analyses (Fig. 4a).